Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on AbbVie (ABBV – Research Report), Molina Healthcare (MOH – Research Report) and Cytokinetics (CYTK – Research Report).
AbbVie (ABBV)
Leerink Partners analyst David Risinger maintained a Hold rating on AbbVie on April 25. The company’s shares closed last Monday at $161.52.
According to TipRanks.com, Risinger is a 5-star analyst with an average return of
Currently, the analyst consensus on AbbVie is a Strong Buy with an average price target of $186.17, implying a 16.7% upside from current levels. In a report issued on April 26, Bank of America Securities also reiterated a Hold rating on the stock with a $172.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Molina Healthcare (MOH)
Mizuho Securities analyst Ann Hynes maintained a Buy rating on Molina Healthcare on April 25 and set a price target of $415.00. The company’s shares closed last Monday at $343.89.
According to TipRanks.com, Hynes is a 5-star analyst with an average return of
Molina Healthcare has an analyst consensus of Moderate Buy, with a price target consensus of $410.00, representing a 19.9% upside. In a report issued on April 15, Truist Financial also maintained a Buy rating on the stock with a $440.00 price target.
Cytokinetics (CYTK)
In a report issued on April 25, Salim Syed from Mizuho Securities maintained a Buy rating on Cytokinetics, with a price target of $99.00. The company’s shares closed last Monday at $62.53.
According to TipRanks.com, Syed has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Cytokinetics with a $101.80 average price target, a 56.7% upside from current levels. In a report issued on April 15, J.P. Morgan also maintained a Buy rating on the stock with a $77.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on ABBV:
